Quick Answer
enVVeno Medical Corp reported Diluted EPS of $33.06 per share (loss) for fiscal year 2025.
enVVeno Medical Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$33.06 | +25.8% |
| 2024 | -$44.53 | -2231.4% |
| 2023 | -$1.91 | +13.2% |
| 2022 | -$2.20 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.23 | +34.3% | +30.3% |
| June 30, 2025 | -$0.33 | -6.5% | -50.0% |
| March 31, 2025 | -$0.22 | +29.0% | +37.1% |
| September 30, 2024 | -$0.35 | +22.2% | -12.9% |
| June 30, 2024 | -$0.31 | +46.6% | +0.0% |
| March 31, 2024 | -$0.31 | +45.6% | +31.1% |
| September 30, 2023 | -$0.45 | +16.7% | +22.4% |
| June 30, 2023 | -$0.58 | +7.9% | -1.8% |
- enVVeno Medical Corp showed an increase of +25.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, enVVeno Medical Corp’s diluted eps has declined by 1402.7% (from $2.20 per share (loss) to $33.06 per share (loss)).
- The most recent figure is from enVVeno Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: